CEBPB and metabolic syndrome: After carrying out NR5A2 knockout or overexpression experiments, it was found that NR5A2 reduced the level of inflammation through CYP7A1/CYP8B1, and C/EBPβ-FASN-SCD1 reduced the level of apoptosis, thereby improving the metabolic syndrome.